AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced ...
depression, physical inactivity, diabetes, excessive drinking, traumatic brain injury, air pollution and social isolation. The latest update adds two more risk factors: vision loss and high ...